KIORA PHARMACEUTICALS INC

Kiora Pharmaceuticals (KPHMW) shows zero cyber incidents and zero red-flag 8-K filings in our 90-day monitoring window, suggesting operational stability in the recent period. However, low signal in this window doesn't mean low risk; the full $49 Report pulls 12 months of filings, adds dilution risk scoring, and contextualizes the company's financing history and AI-detected risk signals. The analysis covers officer departures, restatement triggers, and capital structure vulnerabilities that may not yet be visible in short-term event detection. The full $49 Report adds comprehensive dilution modeling, 12-month 8-K trend analysis, and early-warning signals grounded in SEC filing patterns.